Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
PSA Screening Cost Effective With ‘Smarter’ Approach
...
Already a member? Log in here
VolitionRx Uses Nucleosome Technology for Early Cancer Diagnosis
...
Already a member? Log in here
Methylation Patterns Are New Target for ctDNA Analysis
...
Already a member? Log in here
Disposable, Electrochemical Sensor IDs Wound Infections in Seconds
...
Already a member? Log in here
Adherence Poor for Lynch Syndrome Testing
...
Already a member? Log in here
Few DTC Genetic Test Customers Share Results With Health Providers
From - Diagnostic Testing & Emerging Technologies
While few direct-to-consumer (DTC) genetic testing consumers share their results with a health care provider, most who do are satisfied with the discussion of results…
Survey Finds Expected Growth in Analytical Instrumentation Purchases
From - Diagnostic Testing & Emerging Technologies
A new survey reveals that laboratories are planning to increase equipment purchases this year, with analytical instrumentation reported…
Genetic Risk of Disease Results Don’t Change Health-Related Behaviors
From - Diagnostic Testing & Emerging Technologies
Communicating genetic risk of disease estimates does not impact individuals' health related behaviors, according to a review published March 15 in the…
New Breast Cancer Staging System Incorporates HER2 Status to Better Assess Prognosis
From - Diagnostic Testing & Emerging Technologies
A new breast cancer staging system adds HER2 (ERBB2-positive disease) status to a list of factors used to assess prognosis in women who undergo neoadjuvant (pre-surgical) therapy for…
